missing translation for 'onlineSavingsMsg'
Learn More

Phospho-Tau (Thr181) Monoclonal Antibody (AT270), Invitrogen™

Mouse Monoclonal Antibody

Brand:  Invitrogen MN1050

Code : PN

Additional Details : Weight : 0.68040kg

Product Code. 11808711

  • £642.00 / 100µg
In Stock
to see stock.

Please to purchase this item. Need a web account? Register with us today!


Description

Description

MN1050 recognizes PHF-Tau, tangles and neurofilaments. Cross reacts weakly with normal Tau. Does not cross react with recombinant unphosphorylated Tau. The epitope of this antibody is the phosphorylated Thr181 residue (numbering according to human Tau40). MN1050 detects PHF-tau (Thr181) which has a predicted molecular weight of approximately 79 kDa. Purity is >95% as determined by SDS-PAGE.

Tau is a neuronal microtubule-associated protein found predominantly on axons. The function of Tau is to promote tubulin polymerization and stabilize microtubules. The C-terminus binds axonal microtubules while the N- terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton while the longer isoforms may preferentially play a role in its stabilization. In its hyper-phosphorylated form, Tau is the major component of paired helical filaments (PHF), the building block of neurofibrillary lesions in Alzheimer's diseases (AD) brain. Hyper-phosphorylation impairs the microtubule binding function of Tau, resulting in the destabilization of microtubules in AD brains, μgtimately leading to the degeneration of the affected neurons. Numerous serine/threonine kinases phosphorylate Tau, including GSK-3beta, protein kinase A (PKA), cyclin-dependent kinase 5 (cdk5) and casein kinase II. Hyper-phosphorylated Tau is found in neurofibrillary lesions in a range and other central nervous system disorders such as Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
Specifications

Specifications

Phospho-Tau (Thr181)
Monoclonal
0.2 mg/mL
PBS with no preservative
P10636
MAPT
Partially purified human PHF-Tau
100 μg
Primary
Human
Antibody
IgG1 κ
ELISA, Immunohistochemistry (Paraffin), Western Blot
AT270
Unconjugated
MAPT
AI413597; AW045860; DDPAC; FLJ31424; FTDP17; FTDP-17; G protein beta1/gamma2 subunit-interacting factor 1; map tau; Mapt; MAPTL; MGC138549; microtubule associated protein tau; microtubule-associated protein tau; microtubule-associated protein tau, isoform 4; microtubules; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; neurofibrillary tangles; Neuronal Marker; paired helical filament-tau; PHFtau; PHF-tau; PPND; PPP1R103; protein phosphatase 1, regulatory subunit 103; pTau; RNPTAU; Tau; Tau microtubule-associated protein; tau protein; Tau-4; Tau5; Unknown (protein for MGC:134287)
Mouse
Protein A
RUO
4137
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers